Signal Transduction And Targeted Therapy SCIE

國際簡稱：SIGNAL TRANSDUCT TAR 參考譯名：信號轉(zhuǎn)導與靶向治療

主要研究方向：Biochemistry, Genetics and Molecular Biology-Genetics 非預警期刊審稿周期： 5 Weeks

《信號轉(zhuǎn)導與靶向治療》(Signal Transduction And Targeted Therapy)是一本由Springer Nature出版的以Biochemistry, Genetics and Molecular Biology-Genetics為研究特色的國際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評論文章和綜述文章，及時報道該領(lǐng)域相關(guān)理論、實踐和應用學科的最新發(fā)現(xiàn)，旨在促進該學科領(lǐng)域科學信息的快速交流。該期刊是一本開放期刊，近三年沒有被列入預警名單。該期刊享有很高的科學聲譽，影響因子不斷增加，發(fā)行量也同樣高。

1區(qū) 中科院分區(qū)
Q1 JCR分區(qū)
272 年發(fā)文量
40.8 IF影響因子
開放是否OA
2016 創(chuàng)刊年份
1 issue/year 出版周期
English 出版語言

Signal Transduction and Targeted Therapy (ISSN 2059-3635 (online), ISSN 2095-9907 (print), CN 51-1758/R) is a new open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, including but not limited to: cancer, cardiovascular diseases, autoimmune diseases, and nervous system diseases.

[ 查看全部 ]

投稿咨詢加急咨詢

Signal Transduction And Targeted Therapy期刊信息

ISSN：2095-9907
出版語言：English
是否OA：開放
E-ISSN：2059-3635
出版地區(qū)：United Kingdom
是否預警：否
出版商：Springer Nature
出版周期：1 issue/year
創(chuàng)刊時間：2016
開源占比：1
Gold OA文章占比：99.57%
OA被引用占比：1
出版國人文章占比：0.61
出版撤稿占比：0
研究類文章占比：60.29%

Signal Transduction And Targeted Therapy CiteScore評價數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

44.5

8.737

5.308

學科類別	分區(qū)	排名	百分位
大類：Biochemistry, Genetics and Molecular Biology 小類：Genetics	Q1	2 / 347	99%
大類：Biochemistry, Genetics and Molecular Biology 小類：Cancer Research	Q1	5 / 230	98%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個指標。當年CiteScore 的計算依據(jù)是期刊最近4年（含計算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻數(shù)。例如，2022年的 CiteScore 計算方法為：2022年的 CiteScore =2019-2022年收到的對2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻數(shù)量注：文獻類型包括：文章、評論、會議論文、書籍章節(jié)和數(shù)據(jù)論文。

Signal Transduction And Targeted Therapy中科院評價數(shù)據(jù)

中科院 2023年12月升級版

Top期刊	綜述期刊	大類學科		小類學科
是	否	醫(yī)學	1區(qū)	BIOCHEMISTRY & MOLECULAR BIOLOGY 生化與分子生物學 CELL BIOLOGY 細胞生物學	1區(qū) 1區(qū)

中科院 2022年12月升級版

Top期刊	綜述期刊	大類學科		小類學科
是	否	醫(yī)學	1區(qū)	BIOCHEMISTRY & MOLECULAR BIOLOGY 生化與分子生物學 CELL BIOLOGY 細胞生物學	1區(qū) 1區(qū)

中科院 2021年12月舊的升級版

Top期刊	綜述期刊	大類學科		小類學科
是	否	醫(yī)學	1區(qū)	BIOCHEMISTRY & MOLECULAR BIOLOGY 生化與分子生物學 CELL BIOLOGY 細胞生物學	1區(qū) 1區(qū)

中科院 2021年12月基礎版

Top期刊	綜述期刊	大類學科		小類學科
是	否	醫(yī)學	1區(qū)	BIOCHEMISTRY & MOLECULAR BIOLOGY 生化與分子生物學 CELL BIOLOGY 細胞生物學	1區(qū) 1區(qū)

中科院 2021年12月升級版

Top期刊	綜述期刊	大類學科		小類學科
是	否	醫(yī)學	1區(qū)	BIOCHEMISTRY & MOLECULAR BIOLOGY 生化與分子生物學 CELL BIOLOGY 細胞生物學	1區(qū) 1區(qū)

中科院 2020年12月舊的升級版

Top期刊	綜述期刊	大類學科		小類學科
是	否	醫(yī)學	1區(qū)	BIOCHEMISTRY & MOLECULAR BIOLOGY 生化與分子生物學 CELL BIOLOGY 細胞生物學	1區(qū) 1區(qū)

Signal Transduction And Targeted Therapy JCR評價數(shù)據(jù)（2023-2024年最新版）

按JIF指標學科分區(qū)	收錄子集	分區(qū)	排名	百分位
學科：BIOCHEMISTRY & MOLECULAR BIOLOGY	SCIE	Q1	3 / 313	99.2%
學科：CELL BIOLOGY	SCIE	Q1	5 / 205	97.8%

按JCI指標學科分區(qū)	收錄子集	分區(qū)	排名	百分位
學科：BIOCHEMISTRY & MOLECULAR BIOLOGY	SCIE	Q1	5 / 313	98.56%
學科：CELL BIOLOGY	SCIE	Q1	6 / 205	97.32%

Signal Transduction And Targeted Therapy歷年數(shù)據(jù)統(tǒng)計

影響因子

中科院分區(qū)

Signal Transduction And Targeted Therapy中國學者發(fā)文選摘

1、Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants
Author: Wang, Qian; Yang, Chenchen; Yin, Li; Sun, Jing; Wang, Wei; Li, Hengchun; Zhang, Zhengyuan; Chen, Si; Liu, Bo; Liu, Zijian; Shi, Linjing; Liu, Xiaolin; Guan, Suhua; Wang, Chunhua; Qu, Linbing; Feng, Ying; Niu, Xuefeng; Feng, Liqiang; Zhao, Jincun; Li, Pingchao; Chen, Ling; Zhong, Nanshan

Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2023; Vol. 8, Issue 1, pp. -. DOI: 10.1038/s41392-023-01423-6
2、Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma
Author: Hu, Junhui; Tan, Ping; Ishihara, Moe; Bayley, Nicholas A.; Schokrpur, Shiruyeh; Reynoso, Jeremy G.; Zhang, Yangjun; Lim, Raymond J.; Dumitras, Camelia; Yang, Lu; Dubinett, Steven M.; Jat, Parmjit S.; Van Snick, Jacques; Huang, Jiaoti; Chin, Arnold I.; Prins, Robert M.; Graeber, Thomas G.; Xu, Hua; Wu, Lily

Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2023; Vol. 8, Issue 1, pp. -. DOI: 10.1038/s41392-023-01362-2
3、Combination therapy with saxagliptin and vitamin D for the preservation of beta-cell function in adult-onset type 1 diabetes: a multi-center, randomized, controlled trial
Author: Yan, Xiang; Li, Xia; Liu, Bingwen; Huang, Jiaqi; Xiang, Yufei; Hu, Yuhang; Tang, Xiaohan; Zhang, Ziwei; Huang, Gan; Xie, Zhiguo; Zhou, Houde; Liu, Zhenqi; Wang, Xiangbing; Leslie, Richard David; Zhou, Zhiguang

Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2023; Vol. 8, Issue 1, pp. -. DOI: 10.1038/s41392-023-01369-9
4、Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions
Author: Ma, Jun; Li, Yanan; Yang, Xiangyu; Liu, Kai; Zhang, Xin; Zuo, Xianghao; Ye, Runyu; Wang, Ziqiong; Shi, Rufeng; Meng, Qingtao; Chen, Xiaoping

Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2023; Vol. 8, Issue 1, pp. -. DOI: 10.1038/s41392-023-01430-7
5、RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis
Author: Chen, Lei; Zhang, Wenjing; Chen, Dan; Yang, Quan; Sun, Siwen; Dai, Zhenwei; Li, Zhengzheng; Liang, Xuemei; Chen, Chaoqun; Jiao, Yuexia; Zhi, Lili; Zhao, Lianmei; Zhang, Jinrui; Liu, Xuefeng; Zhao, Jinyao; Li, Man; Wang, Yang; Qi, Yangfan

Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2023; Vol. 8, Issue 1, pp. -. DOI: 10.1038/s41392-023-01367-x
6、Preventive and therapeutic benefits of nelfinavir in rhesus macaques and human beings infected with SARS-CoV-2
Author: Xu, Zhijian; Shi, Danrong; Han, Jian-Bao; Ling, Yun; Jiang, Xiangrui; Lu, Xiangyun; Li, Chuan; Gong, Likun; Ge, Guangbo; Zhang, Yani; Zang, Yi; Song, Tian-Zhang; Feng, Xiao-Li; Tian, Ren-Rong; Ji, Jia; Zhu, Miaojin; Wu, Nanping; Wu, Chunhui; Wang, Zhen; Xu, Yechun; Peng, Cheng; Zheng, Min; Yang, Junling; Du, Feifei; Wu, Junliang; Wang, Peipei; Shen, Jingshan; Zhang, Jianliang; Zheng, Yong-Tang; Yao, Hangping; Zhu, Weiliang

Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2023; Vol. 8, Issue 1, pp. -. DOI: 10.1038/s41392-023-01429-0
7、Targeting integrin pathways: mechanisms and advances in therapy
Author: Pang, Xiaocong; He, Xu; Qiu, Zhiwei; Zhang, Hanxu; Xie, Ran; Liu, Zhiyan; Gu, Yanlun; Zhao, Nan; Xiang, Qian; Cui, Yimin

Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2023; Vol. 8, Issue 1, pp. -. DOI: 10.1038/s41392-022-01259-6
8、SCGN deficiency is a risk factor for autism spectrum disorder
Author: Liu, Zhe; Tan, Shuai; Zhou, Lianyu; Chen, Li; Liu, Mingfeng; Wang, Wang; Tang, Yingying; Yang, Qin; Chi, Sensen; Jiang, Peiyan; Zhang, Yue; Cui, Yonghua; Qin, Junhong; Hu, Xiao; Li, Shenglong; Liu, Qi; Chen, Lu; Li, Song; Burstein, Ezra; Li, Wei; Zhang, Xiaohu; Mo, Xianming; Jia, Da

Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2023; Vol. 8, Issue 1, pp. -. DOI: 10.1038/s41392-022-01225-2